Evidence map›Paper›PMID 26155539›Full record

ArticleJournal of clinical and diagnostic research : JCDR2015

Which is A More Debilitating Disorder Schizophrenia or Dysthymia? - A Comparative Study.

Shaunak A Ajinkya, Pradeep R Jadhav, Shruti Rajamani

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shaunak A AjinkyaProfessor, Department of Psychiatry, MGM Medical College & Hospital , Navi Mumbai, India .
Pradeep R JadhavAssistant Professor, Department of Pharmacology, MGM Medical College & Hospital , Navi Mumbai, India .
Shruti RajamaniStudent, Department of Psychiatry, MGM Medical College & Hospital , Navi Mumbai, India .
Mahatma Gandhi Mission's Dental College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSchizophrenia and Dysthymia are debilitating disorders that affect general health and functioning. Studies show that both vastly affect the quality of life (QOL) of patients and cause great amount of disability.

objectiveTo evaluate and compare the QOL and Disability between patients with Schizophrenia and Dysthymia. MATERIALS AND

methodsA cross sectional, observational, comparative study was done in a randomly chosen sample of 30 outpatients each of schizophrenia and dysthymia. QOL was assessed using WHOQOL-BREF scale and disability was assessed using the Indian Disability Evaluation and Assessment Scale (IDEAS).

resultsPatients of schizophrenia showed greater disability and poorer QOL than patients of dysthymia. The 'Social Relationships' domain of the WHOQOL-BREF scale was the worst affected domain in both groups of patients. Patients with dysthymia also did significantly (p=0.040) better in the 'Psychological' domain; while patients with schizophrenia were significantly (p=0.029) better in the 'Physical Health' domain. Patients with schizophrenia showed greater disability than patients with dysthymia in all the 4 domains of the IDEAS, significantly in the areas of Self care (p<0.001) and Communication-Understanding (p<0.001).

conclusionSchizophrenia is a more debilitating disorder than Dysthymia. This assumes significance when planning rehabilitation models for these disorders.

Indexed as

DisabilityIDEASWHOQOL-BREF

Identifiers

PMID26155539
PMCPMC4484131
OpenAlexW851326261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.